Skip to main content

SOPHiA GENETICS SA

SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
SEC CIK
0001840706

In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 36 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by SOPHiA GENETICS SA insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
36 filings
10 insiders, $2.78M in total
Insiders trading
10
Net value
−$2.78M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for SOPHiA GENETICS SA, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for SOPHiA GENETICS SA
NameTitleLast reported holdingLast filingFilings, past year
Cardoza GeorgeChief Financial Officer308,318Sep 22, 20268
Muken RossChief Executive Officer670,229Sep 22, 202611
Menu PhilippeChief Medical Officer208,387Sep 16, 202619
Xu ZhenyuChief Scientific Officer552,887Sep 16, 202618
Van Well DaanChief Legal Officer338,884Sep 14, 20268
Camblong JurgiExecutive Chairman3,435,822Sep 14, 202619
Hibbs Kathy LDirector96,992Sep 10, 20264
Verma AbhimanyuChief Technology Officer172,171Aug 26, 20267
Valente ManuelaChief People Officer210,450Aug 21, 20268
Puylaert KevinChief Sales Officer147,948Jul 7, 20267
Hirsch DidierDirector240,220Jun 22, 20261
Cox TroyDirector328,743Jun 22, 20261
Ossipow VincentDirector522,860Jun 22, 20261
Cossery Jean-MichelDirector206,212Jun 22, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 20, 2026 (view filing)Mar 191 dayCardoza GeorgeChief Financial OfficerSSale−774$4.79−$3.71K−0.4%184.9K after10b5-1
Mar 20, 2026 (view filing)Mar 191 dayPuylaert KevinChief Sales OfficerSSale−33$4.76−$157.080.0%92.4K after
Mar 20, 2026 (view filing)Mar 191 dayMuken RossPresidentSSale−1.18K$4.79−$5.67K−0.4%271.9K after10b5-1
Mar 20, 2026 (view filing)Mar 191 dayValente ManuelaChief People OfficerSSale−380$4.79−$1.82K−0.2%152.4K after10b5-1
Mar 20, 2026 (view filing)Mar 191 dayXu ZhenyuChief Scientific OfficerSSale−608$4.78−$2.91K−0.1%537.1K after10b5-1
Mar 20, 2026 (view filing)Mar 191 dayMenu PhilippeChief Medical OfficerSSale−608$4.79−$2.91K−0.3%173.6K after10b5-1
Mar 20, 2026 (view filing)Mar 191 dayCamblong JurgiChief Executive OfficerSSale−4.49K$4.77−$21.4K−0.1%3.30M after10b5-1
Mar 20, 2026 (view filing)Mar 191 dayVan Well DaanChief Legal OfficerSSale−684$4.79−$3.28K−0.3%261.2K after10b5-1
Apr 1, 2026 (view filing)Mar 311 dayPuylaert KevinChief Sales OfficerSSale−3$4.71−$14.130.0%92.4K after
Apr 8, 2026 (view filing)Apr 6-72 daysVerma AbhimanyuChief Technology OfficerSSale−3.55K$4.86−$17.3K−1.7%204.4K after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 6-72 daysXu ZhenyuChief Scientific OfficerSSale−5.10K$4.86−$24.8K−0.8%645.0K after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 6-72 daysValente ManuelaChief People OfficerSSale−4.97K$4.86−$24.2K−2.2%219.3K after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 6-72 daysCardoza GeorgeChief Financial OfficerSSale−4.93K$4.86−$24.0K−1.7%292.9K after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 6-72 daysCamblong JurgiChief Executive OfficerSSale−5.10K$4.85−$24.8K−0.1%3.73M after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 6-72 daysMuken RossPresidentSSale−5.02K$4.86−$24.4K−0.7%698.1K after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 6-72 daysVan Well DaanChief Legal OfficerSSale−5.11K$4.86−$24.8K−1.4%353.7K after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 62 daysPuylaert KevinChief Sales OfficerSSale−624$4.86−$3.03K−0.4%148.2K after3 lots
Apr 8, 2026 (view filing)Apr 6-72 daysMenu PhilippeChief Medical OfficerSSale−5.10K$4.86−$24.8K−1.8%281.5K after2 lots10b5-1
Apr 10, 2026 (view filing)Apr 82 daysCardoza GeorgeChief Financial OfficerSSale−1.40K$4.85−$6.80K−0.5%291.5K after10b5-1
Apr 10, 2026 (view filing)Apr 8-92 daysVan Well DaanChief Legal OfficerSSale−4.85K$4.80−$23.3K−1.4%348.8K after2 lots10b5-1
Apr 10, 2026 (view filing)Apr 82 daysValente ManuelaChief People OfficerSSale−3.82K$4.85−$18.5K−1.7%215.5K after10b5-1
Apr 10, 2026 (view filing)Apr 8-92 daysMenu PhilippeChief Medical OfficerSSale−4.73K$4.80−$22.7K−1.7%276.7K after2 lots10b5-1
Apr 10, 2026 (view filing)Apr 8-92 daysXu ZhenyuChief Scientific OfficerSSale−4.74K$4.80−$22.7K−0.7%640.2K after2 lots10b5-1
Apr 10, 2026 (view filing)Apr 8-92 daysMuken RossPresidentSSale−4.74K$4.80−$22.7K−0.7%693.4K after2 lots10b5-1
Apr 10, 2026 (view filing)Apr 8-92 daysCamblong JurgiChief Executive OfficerSSale−4.75K$4.80−$22.8K−0.1%3.72M after2 lots10b5-1
Apr 14, 2026 (view filing)Apr 10-134 daysMenu PhilippeChief Medical OfficerSSale−8.13K$4.72−$38.4K−2.9%268.6K after3 lots10b5-1
Apr 14, 2026 (view filing)Apr 10-134 daysMuken RossPresidentSSale−8.13K$4.73−$38.5K−1.2%685.2K after2 lots10b5-1
Apr 14, 2026 (view filing)Apr 10-134 daysCamblong JurgiChief Executive OfficerSSale−16.6K$4.73−$78.7K−0.4%3.71M after3 lots10b5-1
Apr 14, 2026 (view filing)Apr 10-134 daysXu ZhenyuChief Scientific OfficerSSale−8.12K$4.72−$38.4K−1.3%632.1K after3 lots10b5-1
Apr 14, 2026 (view filing)Apr 104 daysVan Well DaanChief Legal OfficerSSale−2.40K$4.67−$11.2K−0.7%346.4K after10b5-1
Apr 16, 2026 (view filing)Apr 142 daysMuken RossPresidentSSale−2.80K$4.96−$13.9K−0.4%682.4K after10b5-1
Apr 16, 2026 (view filing)Apr 142 daysMenu PhilippeChief Medical OfficerSSale−1.60K$4.96−$7.94K−0.6%267.0K after10b5-1
Apr 16, 2026 (view filing)Apr 14-152 daysCamblong JurgiChief Executive OfficerSSale−60.6K$4.97−$301.3K−1.6%3.65M after2 lots10b5-1
Apr 16, 2026 (view filing)Apr 142 daysXu ZhenyuChief Scientific OfficerSSale−600$4.97−$2.98K−0.1%631.5K after10b5-1
Apr 21, 2026 (view filing)Apr 201 dayPuylaert KevinChief Sales OfficerSSale−33$5.08−$167.640.0%148.2K after
Apr 21, 2026 (view filing)Apr 201 dayMuken RossPresidentSSale−760$5.20−$3.95K−0.1%681.7K after10b5-1
Apr 21, 2026 (view filing)Apr 201 dayMenu PhilippeChief Medical OfficerSSale−608$5.20−$3.16K−0.2%266.4K after10b5-1
Apr 21, 2026 (view filing)Apr 201 dayCamblong JurgiChief Executive OfficerSSale−4.49K$5.21−$23.4K−0.1%3.64M after10b5-1
Apr 21, 2026 (view filing)Apr 201 dayVan Well DaanChief Legal OfficerSSale−684$5.20−$3.56K−0.2%345.7K after10b5-1
Apr 21, 2026 (view filing)Apr 201 dayXu ZhenyuChief Scientific OfficerSSale−608$5.21−$3.17K−0.1%630.9K after10b5-1
Apr 21, 2026 (view filing)Apr 201 dayValente ManuelaChief People OfficerSSale−380$5.20−$1.98K−0.2%215.1K after10b5-1
Apr 28, 2026 (view filing)Apr 271 dayMenu PhilippeChief Medical OfficerSSale−5.00K$4.82−$24.1K−1.9%261.4K after10b5-1
May 12, 2026 (view filing)May 111 dayCamblong JurgiChief Executive OfficerSSale−8.50K$5.09−$43.3K−0.2%3.63M after10b5-1
May 13, 2026 (view filing)May 121 dayMenu PhilippeChief Medical OfficerSSale−5.00K$4.67−$23.4K−1.9%256.4K after10b5-1
May 13, 2026 (view filing)May 121 dayHibbs Kathy LDirectorSSale−7.51K$4.67−$35.1K−7.7%89.8K after10b5-1
May 14, 2026 (view filing)May 131 dayXu ZhenyuChief Scientific OfficerSSale−4.00K$4.54−$18.2K−0.6%626.9K after10b5-1
May 20, 2026 (view filing)May 191 dayPuylaert KevinChief Sales OfficerSSale−33$4.54−$149.820.0%148.2K after
May 20, 2026 (view filing)May 191 dayValente ManuelaChief People OfficerSSale−380$4.60−$1.75K−0.2%214.7K after10b5-1
May 20, 2026 (view filing)May 191 dayVan Well DaanChief Legal OfficerSSale−684$4.60−$3.15K−0.2%345.1K after10b5-1
May 20, 2026 (view filing)May 191 dayMenu PhilippeChief Medical OfficerSSale−608$4.61−$2.80K−0.2%255.8K after10b5-1